Literature DB >> 23784467

Dietary therapy of qi-yin-reinforcing porridge for the alleviation of chemotherapy related symptoms of gastrointestinal tumors: a single-case randomized controlled study.

Cheng-he Zhao1, Bin He, Yu-fei Yang, Juan Liao.   

Abstract

OBJECTIVE: To investigate the efficacy of dietary therapy of qi-yin-reinforcing porridge for the alleviation of clinical symptoms during FOLFOX chemotherapy.
METHODS: A single-case randomized controlled study was carried out. Fourteen patients with gastrointestinal tumors accepting FOLFOX chemotherapy were enrolled using self-crossover control design. On days 1-7 of chemotherapy, the dietary therapy experimental group and the placebo control group were given dietary therapy of qi-yin-reinforcing porridge and dextrin-prepared porridge which had the same appearance, smell, color and taste as the qi-yin-reinforcing porridge, respectively. Fourteen clinical symptoms, including debility, vomiting and nausea, etc. were observed.
RESULTS: Ten patients completed the study and were estimable. The qi-yin-reinforcing porridge demonstrated certain efficacy in alleviating clinical symptoms of patients with gastrointestinal tumors during the period of chemotherapy. Better effect of alleviating debility was found in the dietary therapy experimental group than in the placebo control group, and the difference was statistically significant (Z=2.27, P=0.02). No statistically significant difference was found between the experimental group and the control group with respect to the effect of alleviating the other 13 clinical symptoms including anorexia, nausea, vomiting, dry stool, loose stool, etc. and body weight (P>0.05).
CONCLUSION: Dietary therapy of qi-yin-reinforcing porridge shows an additional benefit in alleviating debility of patients during chemotherapy and deserves clinical use and popularization.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23784467     DOI: 10.1007/s11655-013-1329-y

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  3 in total

1.  [Design and application of single case randomized controlled trial].

Authors:  Jian-ping Liu
Journal:  Zhongguo Zhong Xi Yi Jie He Za Zhi       Date:  2005-03

2.  Fatigue in advanced cancer: a prospective study.

Authors:  Katherine Hauser; Declan Walsh; Lisa A Rybicki; Mellar P Davis; Dilara Seyidova-Khoshknabi
Journal:  Am J Hosp Palliat Care       Date:  2008-06-06       Impact factor: 2.500

Review 3.  Cancer-related fatigue: a practical review.

Authors:  M P O Campos; B J Hassan; R Riechelmann; A Del Giglio
Journal:  Ann Oncol       Date:  2011-02-16       Impact factor: 32.976

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.